Sign In
Buy AORT
$26.83
-0.84 (-3.04%)
At Close: Jul 31, 2026
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results
04:05pm, Thursday, 29'th Jan 2026
ATLANTA, Jan. 29, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter 2025 financial resul
HARBOR CAPITAL ADVISORS, INC. Sells 2 Shares of Artivion Inc (AORT)
01:52pm, Tuesday, 20'th Jan 2026
Summary HARBOR CAPITAL ADVISORS, INC. reduced its stake in Artivion Inc (AORT) by 1.61%, selling 2 shares and holding 122 shares valued at about $10,00
Artivion, Inc. (NYSE:AORT) Receives Average Rating of “Moderate Buy” from Analysts
01:50am, Monday, 12'th Jan 2026
Shares of Artivion, Inc. (NYSE: AORT - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine brokerages that are currently covering the stock, Marketbeat reports. One
Artivion Continues Building Toward Bigger And Better Things
02:04pm, Monday, 29'th Dec 2025
Artivion continues to outperform the med-tech sector, driven by strong execution in stent grafts and On-X valve businesses. Recent clinical updates for the AMDS prosthesis reinforce its safety and eff
Squarepoint Ops LLC Takes $664,000 Position in Artivion, Inc. $AORT
05:10am, Wednesday, 24'th Dec 2025
Squarepoint Ops LLC bought a new position in Artivion, Inc. (NYSE: AORT) during the undefined quarter, according to its most recent filing with the SEC. The institutional investor bought 21,362 shares
Artivion, Inc. (NYSE:AORT) Given Consensus Rating of “Moderate Buy” by Analysts
01:58am, Thursday, 18'th Dec 2025
Artivion, Inc. (NYSE: AORT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine analysts that are presently covering the stock, Marketbeat Ratings reports. One resea
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?
10:41am, Wednesday, 26'th Nov 2025
Here is how Artivion (AORT) and Pacific Biosciences of California (PACB) have performed compared to their sector so far this year.
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Artivion, Inc. (NYSE:AORT)
02:15am, Friday, 21'st Nov 2025
Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Artivion, Inc. (NYSE: AORT). In a filing disclosed on November 18th, the Representative disclosed that they had sold bet
Bridger Management LLC Purchases 68,288 Shares of Artivion, Inc. $AORT
03:50am, Tuesday, 18'th Nov 2025
Bridger Management LLC lifted its position in shares of Artivion, Inc. (NYSE: AORT) by 106.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commiss
Alger Weatherbie Specialized Growth Fund Q3 2025 Portfolio Update
05:09am, Wednesday, 12'th Nov 2025
Class A shares of the Alger Weatherbie Specialized Growth Fund underperformed the Russell 2500 Growth Index during the third quarter of 2025. Semtech Corporation (SMTC), Impinj Inc. (PI), and Artivion
Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript
11:46pm, Thursday, 06'th Nov 2025
Artivion, Inc. ( AORT ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Pat MacKin Lance Berry - EVP, COO, CFO & Treasurer Conference Call Participants Lynn Lewis - Gilmartin G
Artivion (AORT) Tops Q3 Earnings and Revenue Estimates
07:16pm, Thursday, 06'th Nov 2025
Artivion (AORT) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.12 per share a year ago.
Artivion Reports Third Quarter 2025 Financial Results
04:05pm, Thursday, 06'th Nov 2025
Third Quarter Highlights: Achieved revenue of $113.4 million in the third quarter of 2025 versus $95.8 million in the third quarter of 2024, an increase of 18% on a GAAP basis and 16% on a non-GAAP co
Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial
08:00am, Thursday, 06'th Nov 2025
ATLANTA , Nov. 6, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in th
Oppenheimer Asset Management Inc. Takes Position in Artivion, Inc. $AORT
04:05am, Sunday, 02'nd Nov 2025
Oppenheimer Asset Management Inc. purchased a new stake in shares of Artivion, Inc. (NYSE: AORT) during the second quarter, according to its most recent 13F filing with the SEC. The institutional inve
